用二进制变量进行因果调解分析的教程:对健康心理学研究的应用
Shu Xu1, Donna L Coffman2, George Luta3
1Department of Biostatistics, New York University.
概括
本教程介绍了健康心理学中的二元变量因果调解分析. 它侧重于重新采样和权重方法来估计直接和间接的影响,强调时间顺序和混消除.
科学领域:
- 健康心理学 心理健康心理学
- 因果推理因果推理
- 统计方法 统计方法
背景情况:
- 调解分析对于理解健康心理学中的治疗效应至关重要.
- 识别调解者及其影响是一个关键的研究领域.
- 因果调解分析为这些调查提供了一个框架.
研究的目的:
- 引入对二元暴露,调解器和结果变量进行因果调解分析.
- 专注于在潜在结果框架内重新采样和权重方法.
- 为分析提供实用的R代码示例.
主要方法:
- 使用潜在结果框架来估计因果关系.
- 采用重新抽样和权重方法进行分析.
- 用二进制变量定义一个假设的调解链中的因果效应.
主要成果:
- 展示了对二进制数据的因果调解分析的应用.
- 强调时间顺序和混控制的重要性.
- 提供使用"中介"和"medflex"包的功能性R代码示例.
结论:
- 使用二进制变量进行因果调解分析,可以使用重新采样和权重方法有效实施.
- 该教程为健康心理学研究人员提供了实际指导.
- 了解直接和间接的影响对于解释复杂的关系至关重要.
更多相关视频
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
607
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
相关概念视频
Causality in Epidemiology
490
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
490
Criteria for Causality: Bradford Hill Criteria - II
371
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
371
Bias in Epidemiological Studies
369
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
369
Strategies for Assessing and Addressing Confounding
121
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
121
Censoring Survival Data
145
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
145
Hazard Ratio
165
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
165
